These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10334376)

  • 21. Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach.
    Lerner AG; Gelkopf M; Skladman I; Oyffe I; Finkel B; Sigal M; Weizman A
    Isr J Psychiatry Relat Sci; 2002; 39(2):92-9. PubMed ID: 12227234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.
    Dolder PC; Schmid Y; Steuer AE; Kraemer T; Rentsch KM; Hammann F; Liechti ME
    Clin Pharmacokinet; 2017 Oct; 56(10):1219-1230. PubMed ID: 28197931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.
    Holze F; Liechti ME; Hutten NRPW; Mason NL; Dolder PC; Theunissen EL; Duthaler U; Feilding A; Ramaekers JG; Kuypers KPC
    Clin Pharmacol Ther; 2021 Mar; 109(3):658-666. PubMed ID: 32975835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent palinopsia following ingestion of lysergic acid diethylamide (LSD).
    Kawasaki A; Purvin V
    Arch Ophthalmol; 1996 Jan; 114(1):47-50. PubMed ID: 8540850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychedelic microdosing benefits and challenges: an empirical codebook.
    Anderson T; Petranker R; Christopher A; Rosenbaum D; Weissman C; Dinh-Williams LA; Hui K; Hapke E
    Harm Reduct J; 2019 Jul; 16(1):43. PubMed ID: 31288862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dependence on LSD and other hallucinogenic drugs.
    JAMA; 1967 Oct; 202(1):141-4. PubMed ID: 6072003
    [No Abstract]   [Full Text] [Related]  

  • 27. Medical complications of pleasure-giving drugs.
    Louria DB
    Arch Intern Med; 1969 Jan; 123(1):82-7. PubMed ID: 5761741
    [No Abstract]   [Full Text] [Related]  

  • 28. Flashbacks: a personal follow-up.
    Holsten F
    Arch Psychiatr Nervenkr (1970); 1976 Dec; 222(4):293-304. PubMed ID: 1016011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers.
    Bershad AK; Schepers ST; Bremmer MP; Lee R; de Wit H
    Biol Psychiatry; 2019 Nov; 86(10):792-800. PubMed ID: 31331617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of anti-epileptic medication in treating "flashbacks" from hallucinogenic drugs.
    Thurlow HJ; Girvin JP
    Can Med Assoc J; 1971 Nov; 105(9):947-8. PubMed ID: 5150196
    [No Abstract]   [Full Text] [Related]  

  • 31. A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers.
    Ramaekers JG; Hutten N; Mason NL; Dolder P; Theunissen EL; Holze F; Liechti ME; Feilding A; Kuypers KP
    J Psychopharmacol; 2021 Apr; 35(4):398-405. PubMed ID: 32842825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LSD-like panic from risperidone in post-LSD visual disorder.
    Abraham HD; Mamen A
    J Clin Psychopharmacol; 1996 Jun; 16(3):238-41. PubMed ID: 8784656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gynecological-obstetrical problems in female drug users and drug addicts].
    Zumbé FJ; Beck KJ; Schönhöfer PS
    Geburtshilfe Frauenheilkd; 1973 Apr; 33(4):241-53. PubMed ID: 4710014
    [No Abstract]   [Full Text] [Related]  

  • 35. Flashbacks: recurrent intrusive images after the use of LSD.
    Horowitz MJ
    Am J Psychiatry; 1969 Oct; 126(4):565-9. PubMed ID: 5806803
    [No Abstract]   [Full Text] [Related]  

  • 36. A chronic impairment of colour vision in users of LSD.
    Abraham HD
    Br J Psychiatry; 1982 May; 140():518-20. PubMed ID: 6980680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LSD--a pharmacologic profile.
    Rossi GV
    Am J Pharm Sci Support Public Health; 1971; 143(2):38-44. PubMed ID: 4936231
    [No Abstract]   [Full Text] [Related]  

  • 38. The paradoxical psychological effects of lysergic acid diethylamide (LSD).
    Carhart-Harris RL; Kaelen M; Bolstridge M; Williams TM; Williams LT; Underwood R; Feilding A; Nutt DJ
    Psychol Med; 2016 May; 46(7):1379-90. PubMed ID: 26847689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-inflicted testicular amputation in first lysergic acid diethylamide use.
    Blacha C; Schmid MM; Gahr M; Freudenmann RW; Plener PL; Finter F; Connemann BJ; Schönfeldt-Lecuona C
    J Addict Med; 2013; 7(1):83-4. PubMed ID: 23222128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual phenomenology of the LSD flashback.
    Abraham HD
    Arch Gen Psychiatry; 1983 Aug; 40(8):884-9. PubMed ID: 6135405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.